Liquidia (LQDA) Long-Term Debt Issuances (2021 - 2025)
Liquidia's (LQDA) quarterly Long-Term Debt Issuances came in at $50.0 million in Q2 2025, up 100.2% quarter-over-quarter from $25.0 million in Q1 2025.
Liquidia (LQDA) Long-Term Debt Issuances (2021 - 2025) Analysis & Trends
Liquidia's Long-Term Debt Issuances history runs 5 years deep, the most recent figure standing at $50.0 million for Q2 2025.
- On a quarterly basis, Long-Term Debt Issuances changed N/A year-over-year to $50.0 million in Q2 2025; TTM through Mar 2026 was $50.0 million, a 12.98% decrease from a year earlier, with the FY2025 full-year figure at $75.0 million, up 30.48% from the prior year.
- Long-Term Debt Issuances improved to $50.0 million in Q2 2025 per LQDA's latest filing, from $25.0 million in the prior quarter.
- Across five years, Long-Term Debt Issuances topped out at $50.0 million in Q2 2025 and bottomed at $2.2 million in Q1 2023.
- The 5-year median for Long-Term Debt Issuances is $25.0 million (2024), against an average of $25.5 million.
- Across the five-year window, Long-Term Debt Issuances soared 1040.41% in 2024 and changed 0.0% in 2025, its largest moves.
- Year by year, Long-Term Debt Issuances stood at $10.4 million in 2021, then surged by 89.88% to $19.8 million in 2022, then soared by 100.1% to $39.6 million in 2023, then declined by 17.87% to $32.5 million in 2024, then surged by 53.92% to $50.0 million in 2025.
- Per Business Quant, the three latest LQDA Long-Term Debt Issuances figures stand at $50.0 million (Q2 2025), $25.0 million (Q1 2025), and $32.5 million (Q3 2024).
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Long-Term Debt Issuances (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 91.93 Bn | 90.07 Bn | - | - |
| 2 | Teva Pharmaceutical Industries | 36.15 Bn | 32.41 Bn | 1.97 Bn | - |
| 3 | Zoetis | 33.13 Bn | 31.19 Bn | 1.62 Bn | - |
| 4 | Takeda Pharmaceutical | 27.85 Bn | 23.79 Bn | 4.39 Bn | 3.64 Bn |
| 5 | United Therapeutics | 22.98 Bn | 20.82 Bn | 648.10 Mn | - |
| 6 | RedHill Biopharma | 21.11 Bn | 21.11 Bn | - | - |
| 7 | Viatris | 20.58 Bn | 18.78 Bn | 1.16 Bn | - |
| 8 | Neurocrine Biosciences | 18.02 Bn | 16.71 Bn | 800.70 Mn | - |
| 9 | Elanco Animal Health | 12.79 Bn | 12.36 Bn | 785.00 Mn | - |
| 10 | Liquidia | 7.35 Bn | 7.13 Bn | 121.79 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2025 | 50.00 Mn |
| Jun 30, 2025 | 50.00 Mn |
| Mar 31, 2025 | 24.98 Mn |
| Mar 31, 2025 | 24.98 Mn |
| Sep 30, 2024 | 32.49 Mn |
| Sep 30, 2024 | 32.49 Mn |
| Mar 31, 2024 | 24.98 Mn |
| Mar 31, 2024 | 24.98 Mn |
| Dec 31, 2023 | 39.55 Mn |
| Dec 31, 2023 | 39.55 Mn |
| Mar 31, 2023 | 2.19 Mn |
| Mar 31, 2023 | 2.19 Mn |
| Jun 30, 2022 | 19.77 Mn |
| Jun 30, 2022 | 19.77 Mn |
| Mar 31, 2021 | 10.41 Mn |
| Mar 31, 2021 | 10.41 Mn |